Research Paper Volume 12, Issue 18 pp 18676—18692

Identification of genomic alterations and associated transcriptomic profiling reveal the prognostic significance of MMP14 and PKM2 in patients with pancreatic cancer

class="figure-viewer-img"

Figure 5. Validation of the prognosis of MMP14 and PKM2 in three GEO datasets. (A) Kaplan-Meier survival analysis was used to compare the overall survival of MMP14 highly expressed patients (red) with MMP14 lowly expressed patients (black) in GSE21250, GSE28735 and GSE57495 datasets. P values were generated from Log-rank test. (B) Kaplan-Meier survival analysis was used to compare the overall survival of PKM2 highly expressed patients (red) with PKM2 lowly expressed patients (black) in GSE21250, GSE28735 and GSE57495 datasets.